A sporadic but serious fungal infection, known as mucormycosis and colloquially as “black fungus”, is being detected fairly frequently among Covid-19 patients in some states. The disease often displays in the skin and also affects the lungs and the brain. With a number of mucormycosis cases detected in Delhi, Maharashtra and Gujarat, experts in the national Covid-19 task force on Sunday issued an evidence-based advisory on the disease.
The mucormycosis infection, triggered by Covid-19, is curable but if left untreated or if the treatment is delayed, the rare infection can lead to loss of vision, and in some cases, increase the risk of death. What exactly is mucormycosis infection? Who is at risk from mucormycosis? What are the symptoms and treatment of the mucormycosis fungal infection?
Mucormycosis was formerly called zygomycosis. Mucormycosis is a serious but rare fungal infection that has been affecting recovered or recovering Covid-19 patients. According to the US Centre for Diseases Control and Prevention (CDC), mucormycosis or “black fungus” infection is caused by a group of molds called mucormycetes that are widely found in the environment.
Mucormycosis chiefly affects people who have health problems or have been on medicines that lower the body’s ability to fight germs and sickness. The symptoms of mucormycosis depend on where in the body the fungus is growing i.e., the sinus, brain, lungs or the skin.
So, keep a regular check to ensure that you get treatment for black fungus.